[go: up one dir, main page]

SG10201710218RA - Sc-beta cells and compositions and methods for generating the same - Google Patents

Sc-beta cells and compositions and methods for generating the same

Info

Publication number
SG10201710218RA
SG10201710218RA SG10201710218RA SG10201710218RA SG10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA SG 10201710218R A SG10201710218R A SG 10201710218RA
Authority
SG
Singapore
Prior art keywords
compositions
generating
methods
same
beta cells
Prior art date
Application number
SG10201710218RA
Inventor
Quinn P Peterson
Felicia J Pagliuca
Douglas A Melton
Jeffrey R Millman
Michael Saris Segel
Mads Gürtler
Alireza Rezania
Benjamin Fryer
Original Assignee
Harvard College
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Janssen Biotech Inc filed Critical Harvard College
Publication of SG10201710218RA publication Critical patent/SG10201710218RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/375—Thyroid stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/395—Thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/22—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201710218RA 2013-06-11 2014-06-11 Sc-beta cells and compositions and methods for generating the same SG10201710218RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361833898P 2013-06-11 2013-06-11
US201461972212P 2014-03-28 2014-03-28

Publications (1)

Publication Number Publication Date
SG10201710218RA true SG10201710218RA (en) 2018-01-30

Family

ID=52022750

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201710218RA SG10201710218RA (en) 2013-06-11 2014-06-11 Sc-beta cells and compositions and methods for generating the same
SG11201510176VA SG11201510176VA (en) 2013-06-11 2014-06-11 SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
SG11201510177WA SG11201510177WA (en) 2013-06-11 2014-06-11 SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG11201510176VA SG11201510176VA (en) 2013-06-11 2014-06-11 SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
SG11201510177WA SG11201510177WA (en) 2013-06-11 2014-06-11 SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME

Country Status (17)

Country Link
US (16) US20170029778A1 (en)
EP (4) EP4461806A3 (en)
JP (8) JP6677634B2 (en)
KR (12) KR102773841B1 (en)
CN (5) CN120796168A (en)
AU (6) AU2014284677B2 (en)
BR (2) BR112015030946A8 (en)
CA (2) CA2915091A1 (en)
DE (2) DE202014011287U1 (en)
DK (1) DK3008168T3 (en)
GB (3) GB2531952C (en)
HK (1) HK1257187B (en)
MX (2) MX2015017103A (en)
PH (1) PH12015502767A1 (en)
RU (2) RU2016100219A (en)
SG (3) SG10201710218RA (en)
WO (2) WO2014201167A1 (en)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185693B1 (en) 2007-07-31 2019-07-03 Lifescan, Inc. Differentiation of human embryonic stem cells
CN107574142B (en) 2007-11-27 2021-07-06 生命扫描有限公司 Differentiation of human embryonic stem cells
SG11201403473QA (en) 2011-12-22 2014-10-30 Janssen Biotech Inc Differentiation of human embryonic stem cells into single hormonal insulin positive cells
KR101942769B1 (en) 2012-12-31 2019-01-28 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
WO2014168973A2 (en) * 2013-04-08 2014-10-16 President And Fellows Of Harvard College Methods and compositions for rejuvenating skeletal muscle stem cells
CN120796168A (en) 2013-06-11 2025-10-17 哈佛学院校长同事会 SC-beta cells, compositions and methods for producing the same
CN117821369A (en) 2014-05-16 2024-04-05 詹森生物科技公司 Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
WO2016100930A1 (en) * 2014-12-18 2016-06-23 President And Fellows Of Harvard College Methods for generating stem cell-derived b cells and methods of use thereof
US20160175363A1 (en) * 2014-12-18 2016-06-23 President And Fellows Of Harvard College Methods for generating stem cell-derived beta cells and uses thereof
US10443042B2 (en) 2014-12-18 2019-10-15 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof
WO2016100909A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF
WO2016100857A1 (en) * 2014-12-19 2016-06-23 Regeneron Pharmaceuticals, Inc. Stem cells for modeling type 2 diabetes
EP3286563B1 (en) 2015-04-23 2022-11-02 The Regents of The University of California Controlled induction of human pancreatic progenitors produces functional beta-like cells
EP3285572B1 (en) * 2015-04-24 2020-12-02 University of Copenhagen Method for production of insulin-producing cells
EP3286300B1 (en) * 2015-04-24 2020-10-21 University of Copenhagen Isolation of bona fide pancreatic progenitor cells
EP3328404A4 (en) * 2015-07-27 2018-12-26 The Regents of The University of California Methods and compositions for producing pancreatic beta cells
US11499140B2 (en) * 2015-10-29 2022-11-15 Juntendo Educational Foundation Method for producing pancreatic endocrine cells, and transdifferentiation agent
EP3386543B1 (en) 2015-11-10 2021-07-21 City of Hope Conditioning regimens and methods for inducing mixed chimerism
US20190000889A1 (en) * 2015-12-31 2019-01-03 City Of Hope Methods for treating diabetes
EP3949979A1 (en) * 2016-01-06 2022-02-09 President and Fellows of Harvard College Treatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis
US20190018000A1 (en) 2016-01-12 2019-01-17 Cedars-Sinai Medical Center A method of non destructive monitoring of biological processes in microfluidic tissue culture systems
AU2017213795A1 (en) 2016-02-01 2018-08-16 Cedars-Sinai Medical Center Systems and methods for growth of intestinal cells in microfluidic devices
WO2017144695A1 (en) * 2016-02-24 2017-08-31 Novo Nordisk A/S Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
CA3014662A1 (en) * 2016-03-02 2017-09-08 Frequency Therapeutics, Inc. Methods for controlled proliferation of vestibular stem cells / generating inner ear hair cells using wnt and tgf-beta inhibition
MA45329A (en) * 2016-04-08 2019-02-13 Univ California PRODUCTION OF FULLY FUNCTIONAL MATURE BETA CELLS FROM HUMAN PANCREATIC PROGENITORS
US20190151371A1 (en) * 2016-06-09 2019-05-23 Georgetown University Process for continuous cell culture of islet cells
MA45502A (en) * 2016-06-21 2019-04-24 Janssen Biotech Inc GENERATION OF FUNCTIONAL BETA CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS WITH GLUCOSE-DEPENDENT MITOCHONDRIAL RESPIRATION AND TWO-PHASE INSULIN SECRETION RESPONSE
WO2018094114A2 (en) * 2016-11-16 2018-05-24 Allele Biotechnology & Pharmaceuticals, Inc. Induction of pancreatic beta cells by stem cell differentiation with rna
US11913022B2 (en) 2017-01-25 2024-02-27 Cedars-Sinai Medical Center In vitro induction of mammary-like differentiation from human pluripotent stem cells
KR101745297B1 (en) 2017-02-02 2017-06-09 경북대학교 산학협력단 Composition for diagnosis of obesity and uses thereof
US11767513B2 (en) 2017-03-14 2023-09-26 Cedars-Sinai Medical Center Neuromuscular junction
WO2018176001A2 (en) 2017-03-24 2018-09-27 Cedars-Sinai Medical Center Methods and compositions for production of fallopian tube epithelium
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
IL313825B2 (en) 2017-06-14 2025-07-01 Vertex Pharma Devices and methods for delivering therapeutics
WO2019005871A1 (en) * 2017-06-26 2019-01-03 City Of Hope Methods of islet cell culture
US10391156B2 (en) 2017-07-12 2019-08-27 Viacyte, Inc. University donor cells and related methods
WO2019018818A1 (en) * 2017-07-21 2019-01-24 Semma Therapeutics, Inc. Re-aggregation of stem cell-derived pancreatic beta cells
CA2983845C (en) 2017-10-26 2024-01-30 University Of Copenhagen Generation of glucose-responsive beta cells
AU2018370029B2 (en) 2017-11-15 2024-11-07 Vertex Pharmaceuticals Incorporated Islet cell manufacturing compositions and methods of use
EP3758719A4 (en) * 2018-03-02 2021-12-08 Vertex Pharmaceuticals Inc. METHOD FOR INCREASING STEM CELL DIFFERENTIATION IN BETA CELLS
EP3768823B1 (en) * 2018-03-23 2025-12-31 Cedars-Sinai Medical Center METHOD FOR THE USE OF ISLAND CELLS
EP3775161A4 (en) 2018-04-06 2022-04-06 Cedars-Sinai Medical Center NEURODEGENERATIVE DISEASE MODELS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS ON A MICROFLUIDIC CHIP
US11981918B2 (en) 2018-04-06 2024-05-14 Cedars-Sinai Medical Center Differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells
US12421499B2 (en) 2018-05-11 2025-09-23 Cornell University Method of differentiation of human pluripotent stem cells to monohormonal cells
AU2019320072A1 (en) 2018-08-10 2021-02-25 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
JP2021533788A (en) 2018-08-17 2021-12-09 フリークエンシー セラピューティクス インコーポレイテッド Compositions and Methods for Generating Hair Cells by Up-Controlling JAG-1
US11617745B2 (en) 2018-08-17 2023-04-04 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating FOXO
WO2020043292A1 (en) * 2018-08-30 2020-03-05 Novo Nordisk A/S Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors
US12378572B2 (en) 2018-09-07 2025-08-05 Crispr Therapeutics Ag Universal donor cells
WO2020061591A1 (en) 2018-09-21 2020-03-26 President And Fellows Of Harvard College Methods and compositions for treating diabetes, and methods for enriching mrna coding for secreted proteins
AU2019347876A1 (en) * 2018-09-28 2021-05-13 Memorial Sloan-Kettering Cancer Center Stem cell-derived human microglial cells, methods of making and methods of use
CN112888778B (en) * 2018-10-15 2025-06-03 埃维亚生命科学有限公司 Method for preparing stem cells/progenitor cells from cells derived from endoderm tissue or organ by using low molecular weight compounds
KR102115960B1 (en) * 2018-11-28 2020-05-27 송미연 A method of differentiating human mesenchymal stem cells to thyrotropic cells
WO2020206046A1 (en) 2019-04-01 2020-10-08 The Broad Institute, Inc. Methods and compositions for cell therapy
CN113728090B (en) * 2019-04-08 2024-04-05 诺和诺德股份有限公司 Pancreatic endoderm generation from stem cell-derived definitive endoderm
EP4386081A3 (en) 2019-05-21 2024-10-16 President and Fellows of Harvard College Endocrine differentiation-inducing molecule
KR102167257B1 (en) * 2019-05-28 2020-10-19 부산대학교 산학협력단 Method of promoting differentiation of stem cells into mature cardiomyocytes using tomatidine
AU2020283056B2 (en) 2019-05-31 2023-06-08 Viacyte, Inc. A biocompatible membrane composite
WO2020243663A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
CN114401752B (en) 2019-05-31 2023-04-04 W.L.戈尔及同仁股份有限公司 Cell encapsulation device with controlled oxygen diffusion distance
US20220233298A1 (en) 2019-05-31 2022-07-28 W. L. Gore & Associates, Inc. A biocompatible membrane composite
WO2020247954A1 (en) * 2019-06-06 2020-12-10 President And Fellows Of Harvard College Compositions and methods for maturing stem cell-derived beta cells
WO2020264072A1 (en) 2019-06-25 2020-12-30 Semma Therapeutics, Inc. Enhanced differentiation of beta cells
WO2021030424A1 (en) * 2019-08-13 2021-02-18 Semma Therapeutics, Inc. Pancreatic differentiation
US10740609B1 (en) * 2019-08-30 2020-08-11 Numerica Corporation System and method for space object detection in daytime sky images
KR20220052370A (en) 2019-09-05 2022-04-27 크리스퍼 테라퓨틱스 아게 universal donor cells
US11116798B2 (en) 2019-09-05 2021-09-14 Crispr Therapeutics Ag Universal donor cells
AU2020361709A1 (en) * 2019-10-10 2022-05-26 The Regents Of The University Of Colorado, A Body Corporate Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells
US20230014430A1 (en) * 2019-11-20 2023-01-19 Washington University Methods and Compositions for Generating Functionally Mature Beta Cells and Uses Thereof
WO2021167703A1 (en) 2020-02-19 2021-08-26 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing tgfb antagonist prodrugs useful in the treatment of cancer and methods thereof
CN111269875B (en) * 2020-03-24 2022-04-08 山东兴瑞生物科技有限公司 Method for directionally differentiating into islet cells by using autoimmune cells
WO2021212044A1 (en) * 2020-04-16 2021-10-21 Washington University Methods and compositions for improving sc-beta cells or enhancing their utility
US12473537B2 (en) 2020-06-16 2025-11-18 The Broad Institute, Inc. Three-dimensional cell culture, devices, and use thereof
WO2022026932A2 (en) 2020-07-31 2022-02-03 Vertex Pharmaceuticals Incorporated Differentiation of pancreatic endocrine cells
EP4189066A4 (en) * 2020-07-31 2024-10-23 Vertex Pharmaceuticals Incorporated In vitro differentiation of pancreatic endocrine cells
AU2021414617A1 (en) 2020-12-31 2023-08-10 Crispr Therapeutics Ag Universal donor cells
CN112980771B (en) * 2021-03-05 2023-12-19 贝康医学科技有限公司 Method for preparing pancreatic beta cells and application thereof
CN113046299B (en) * 2021-03-19 2024-06-28 上海爱萨尔生物科技有限公司 An additive for preparing pancreatic β cells by induced pluripotent stem cell directed differentiation
CN112980774B (en) * 2021-03-19 2022-04-01 上海爱萨尔生物科技有限公司 Culture method for preparing islet beta cells by inducing pluripotent stem cells to differentiate directionally
CN112961823B (en) * 2021-03-19 2024-01-23 上海爱萨尔生物科技有限公司 A culture medium for preparing pancreatic islet beta cells through directed differentiation of induced pluripotent stem cells
CN113234664B (en) * 2021-05-11 2024-05-10 澳门大学 Preparation method and application of pancreatic progenitor cells
US20220403340A1 (en) * 2021-06-11 2022-12-22 Washington University Media for cryopreserved cells and methods of making and using same
WO2023278382A1 (en) 2021-06-29 2023-01-05 Staffan Holmin Endoluminal delivery cannula
KR20240057433A (en) 2021-09-21 2024-05-02 각코호진 오키나와가가쿠기쥬츠다이가쿠인 다이가쿠가쿠엔 Platform for drug testing for synucleinopathies using human brain organoids
JP2024540987A (en) 2021-10-21 2024-11-06 バーテックス ファーマシューティカルズ インコーポレイテッド Low immune cells
WO2023072170A1 (en) * 2021-10-28 2023-05-04 Sunshine Lake Pharma Co., Ltd. A METHOD FOR PROMOTING THE DIFFERENTIATION OF STEM CELLS INTO FUNCTIONALLY MATURE ISLET β CELLS AND USE THEREOF
EP4426814A2 (en) 2021-11-01 2024-09-11 Vertex Pharmaceuticals Incorporated Stem cell derived pancreatic islet differentiation
JP2024543217A (en) * 2021-11-30 2024-11-19 ハンチョウ リプロジェニックス バイオサイエンス，インコーポレイテッド Methods for generating functional pancreatic islets from pluripotent stem cells
JP2025505582A (en) * 2022-02-01 2025-02-28 バーテックス ファーマシューティカルズ インコーポレイテッド Cell therapy for diabetes
US12435312B2 (en) 2022-02-28 2025-10-07 Brown University Quantifying cell-derived changes in collagen synthesis, alignment, and mechanics in a 3D connective tissue model
IL316370A (en) 2022-04-15 2024-12-01 Smartcella Solutions Ab Compositions and methods for exosome-mediated delivery of messenger RNA factors
EP4531873A1 (en) * 2022-06-03 2025-04-09 Cornell University Derivation of glucose-responsive insulin-secreting cells and organoids from human stomach cells and their use to treat diabetes
EP4608977A1 (en) * 2022-10-28 2025-09-03 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for accelerated production of thymic cells from pluripotent stem cells
WO2024151541A1 (en) * 2023-01-09 2024-07-18 Sana Biotechnology, Inc. Type-1 diabetes autoimmune mouse
WO2024151804A2 (en) * 2023-01-11 2024-07-18 Mayo Foundation For Medical Education And Research Methods and materials for generating stem cell-derived endocrine cell types
IL322348A (en) 2023-02-14 2025-09-01 Vertex Pharma Macroencapsulation devices including immunomodulatory compounds
WO2024243236A2 (en) 2023-05-22 2024-11-28 Sana Biotechnology, Inc. Methods of delivery of islet cells and related methods
WO2025029671A1 (en) * 2023-07-28 2025-02-06 Vertex Pharmaceuticals Incorporated Cell therapy for diabetes
CN117672411B (en) * 2023-12-05 2024-05-14 首都医科大学附属北京世纪坛医院 A method for studying the Hormesis effect of a traditional Chinese medicine ingredient and the application of berberine, a traditional Chinese medicine ingredient

Family Cites Families (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774A (en) 1849-10-09 Improved jointed center-board
US130A (en) 1837-02-16 Improvement in metallic solutions for the preservation of timber
US3270960A (en) 1964-09-11 1966-09-06 Sperry Rand Corp Fluid sensor
DE1570610C3 (en) 1965-10-01 1974-08-01 Bayer Ag, 5090 Leverkusen Process for the production of poly-N-oxides
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4378016A (en) 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
US5425764A (en) 1992-07-30 1995-06-20 The University Of Toledo Bioartificial pancreas
US6469017B1 (en) 1998-01-16 2002-10-22 Cell Therapeutics, Inc. Method of inhibiting interleukin-12 signaling
US7018419B2 (en) 1994-05-20 2006-03-28 Spielberg Theodore E Microporous encapsulated endocrine cell disks, biconcave disks and multidimpled chambers for hormonal replacement
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
AU720662B2 (en) 1995-04-07 2000-06-08 Albert Einstein College Of Medicine Of Yeshiva University Recombinant B-cell and uses thereof
US6187991B1 (en) 1995-05-23 2001-02-13 Pfizer Inc Transgenic animal models for type II diabetes mellitus
CA2218623A1 (en) 1996-02-23 1997-08-28 Circe Biomedical, Inc. Novel artificial pancreas
US5994619A (en) 1996-04-01 1999-11-30 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Production of chimeric bovine or porcine animals using cultured inner cell mass cells
FI990655A7 (en) 1996-10-01 1999-06-01 Geron Corp Catalytic subunit of human telomerase
US5945577A (en) 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
AU5734998A (en) 1997-01-10 1998-08-03 Life Technologies, Inc. Embryonic stem cell serum replacement
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
WO1999020741A1 (en) 1997-10-23 1999-04-29 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
WO2001051610A1 (en) 2000-01-14 2001-07-19 Bresagen Limited Ectoderm cell production
GB0005251D0 (en) 2000-03-03 2000-04-26 Merck Sharp & Dohme Therapeutic compounds
US6436704B1 (en) 2000-04-10 2002-08-20 Raven Biotechnologies, Inc. Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US20020009743A1 (en) 2000-05-17 2002-01-24 Carpenter Melissa K. Neural progenitor cell populations
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US6906810B2 (en) 2000-07-13 2005-06-14 Morgan Guaranty Trust Company Method and system for allowing an on-line user to selectively customize a document for printing in a single batch process
US7163918B2 (en) 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US6916640B2 (en) 2000-10-12 2005-07-12 Agency For Science, Technology And Research Multi-layer cell encapsulation for tissue engineering
CA2425356C (en) 2000-10-13 2015-10-06 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
US6576464B2 (en) 2000-11-27 2003-06-10 Geron Corporation Methods for providing differentiated stem cells
EP1366148A2 (en) 2001-01-24 2003-12-03 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES Differentiation of stem cells to pancreatic endocrine cells
WO2002092756A2 (en) 2001-05-15 2002-11-21 Rappaport Family Institute For Research In The Medical Sciences Insulin producing cells derived from human embryonic stem cells
US7432104B2 (en) 2001-08-06 2008-10-07 Bresgen Inc. Methods for the culture of human embryonic stem cells on human feeder cells
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
WO2003033697A1 (en) 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
US20030077256A1 (en) 2001-10-19 2003-04-24 Paul Czernichow Pancreas regeneration using embryonic pancreatic cells
US7157278B2 (en) 2001-12-04 2007-01-02 Organogenesis, Inc. Cultured cells from pancreatic islets
CN1630716A (en) 2001-12-07 2005-06-22 杰龙公司 Human embryonic stem cell-derived hematopoietic cells
JP4666567B2 (en) 2001-12-07 2011-04-06 ジェロン・コーポレーション Islet cells derived from human embryonic stem cells
DK1921133T3 (en) 2001-12-07 2015-08-24 Cytori Therapeutics Inc System for processing lipoaspiratceller
US20060003446A1 (en) 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
EP1507552A2 (en) 2002-05-28 2005-02-23 Novocell, Inc. Methods, compositions, and growth and differentiation factors for insulin-producing cells
US20060122104A1 (en) 2002-05-28 2006-06-08 Presnell Sharon C Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
EP1567639A4 (en) 2002-12-05 2005-12-21 Technion Res & Dev Foundation Cultured human pancreatic islets, and uses thereof
AU2003300522A1 (en) 2002-12-27 2004-07-22 Bayer Healthcare Ag 4-phenyl-pyrimido (4,5-b) indole derivatives
US7172682B2 (en) 2003-01-24 2007-02-06 Rensselaer Polytechnic Institute Enzyme immobilization for electroosmotic flow
US20030224411A1 (en) 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
US7084246B2 (en) 2003-04-17 2006-08-01 Molecular Logix, Inc. Epidermal growth factor agonists
WO2005063971A2 (en) 2003-12-23 2005-07-14 Cythera, Inc Definitive endoderm
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
US8586357B2 (en) 2003-12-23 2013-11-19 Viacyte, Inc. Markers of definitive endoderm
US7625753B2 (en) 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
US7541185B2 (en) 2003-12-23 2009-06-02 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
US20090155218A1 (en) 2004-03-10 2009-06-18 Alberto Hayek Compositions and methods for growth of embryonic stem cells
CN1960966A (en) 2004-03-30 2007-05-09 加利福尼亚大学董事会 Hydrazide-containing CFTR inhibitor compounds and uses thereof
JP2005278501A (en) * 2004-03-30 2005-10-13 Asahi Kasei Corp Method for differentiating and inducing pancreatic stem cell
JP4491014B2 (en) 2004-04-01 2010-06-30 ウイスコンシン アラムニ リサーチ ファンデーション Differentiation of stem cells into endoderm and pancreatic lineages
EP2377922B1 (en) 2004-04-27 2020-04-08 Viacyte, Inc. PDX1 expressing endoderm
EP2267116B1 (en) 2004-07-13 2017-05-31 Asterias Biotherapeutics, Inc. Growth medium for primate embryonic stem cells
KR20070083559A (en) 2004-08-13 2007-08-24 더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 Compositions and Methods for Self-renewal and Differentiation in Human Embryonic Stem Cells
US7517870B2 (en) 2004-12-03 2009-04-14 Fondazione Telethon Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
EP1676574A3 (en) 2004-12-30 2006-07-26 Johnson & Johnson Vision Care, Inc. Methods for promoting survival of transplanted tissues and cells
WO2006083782A2 (en) 2005-01-31 2006-08-10 Es Cell International Pte Ltd. Directed differentiation of embryonic stem cells and uses thereof
JP5017253B2 (en) 2005-03-31 2012-09-05 ステムニオン，インコーポレイテッド Amnion-derived cell composition, preparation method and use thereof
CN101228264B (en) 2005-06-22 2017-12-26 阿斯特利亚斯生物治疗股份公司 PPS is set to be divided into cardiomyocyte-lineage cells
CN107189980B (en) 2005-06-22 2021-07-09 阿斯特利亚斯生物治疗股份公司 Suspension culture of human embryonic stem cells
AU2006270066A1 (en) 2005-07-19 2007-01-25 University Of Tennessee Research Foundation LPA2 receptor agonist inhibitors of CFTR
CN101351547A (en) 2005-10-27 2009-01-21 赛瑟拉公司 Dorsal and ventral foregut endoderm expressing PDX1
JP2009519977A (en) 2005-12-16 2009-05-21 アルコン，インコーポレイテッド Control of intraocular pressure using ALK5 regulator
WO2007075807A2 (en) 2005-12-20 2007-07-05 Es Cell International Pte Ltd. Methods for the directed differentiation of embryonic stem cell
AU2007207434B2 (en) 2006-01-20 2012-04-05 Reneuron, Inc. Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture
JPWO2007088651A1 (en) 2006-02-01 2009-06-25 国立大学法人 東京大学 Combination use of TGF-β signal inhibitor and antitumor agent
US7973011B2 (en) 2006-02-13 2011-07-05 The Board Of Trustees Of The Leland Stanford Junior University Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
CN113088483A (en) 2006-02-23 2021-07-09 维亚赛特公司 Compositions and methods for culturing differentiable cells
DK2650360T3 (en) * 2006-03-02 2019-10-07 Viacyte Inc Endocrine precursor cells, pancreatic hormone-expressing cells, and methods of preparation
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
US8247531B2 (en) 2006-03-20 2012-08-21 Cochran Jennifer R Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor
CA2984541C (en) 2006-04-28 2022-04-12 Lifescan, Inc. Differentiation of human embryonic stem cells
US7964402B2 (en) 2006-05-25 2011-06-21 Sanford-Burnham Medical Research Institute Methods for culture and production of single cell populations of human embryonic stem cells
WO2007143193A1 (en) * 2006-06-02 2007-12-13 University Of Georgia Research Foundation, Inc. Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems
WO2007149182A2 (en) 2006-06-19 2007-12-27 Geron Corporation Differentiation and enrichment of islet-like cells from human pluripotent stem cells
WO2008013664A2 (en) 2006-07-26 2008-01-31 Cythera, Inc. Methods of producing pancreatic hormones
CN101528166B (en) 2006-08-29 2014-05-07 阿克伦大学 Implantable device for producing insulin
EP2118309B1 (en) * 2006-12-29 2015-01-28 The Regents of the University of Colorado, a body corporate Diagnostic and therapeutic target for autoimmune diseases and uses thereof
WO2008102000A1 (en) * 2007-02-21 2008-08-28 Sarl Endocells Human pancreatic beta cell lines for diagnostic of diabetes
JP2010523579A (en) 2007-04-02 2010-07-15 インスティテュート フォア ワンワールド ヘルス CFTR inhibitor compounds and their use
JP5738591B2 (en) 2007-07-18 2015-06-24 ライフスキャン・インコーポレイテッドＬｉｆｅｓｃａｎ，Ｉｎｃ． Differentiation of human embryonic stem cells
EP2185693B1 (en) 2007-07-31 2019-07-03 Lifescan, Inc. Differentiation of human embryonic stem cells
US8501813B2 (en) 2007-08-09 2013-08-06 Kabushiki Kaisha Yakult Honsha γ-secretase inhibitor
US7695963B2 (en) 2007-09-24 2010-04-13 Cythera, Inc. Methods for increasing definitive endoderm production
US8623650B2 (en) 2007-10-19 2014-01-07 Viacyte, Inc. Methods and compositions for feeder-free pluripotent stem cell media containing human serum
CN107574142B (en) 2007-11-27 2021-07-06 生命扫描有限公司 Differentiation of human embryonic stem cells
SG154367A1 (en) 2008-01-31 2009-08-28 Es Cell Int Pte Ltd Method of differentiating stem cells
US8507501B2 (en) 2008-03-13 2013-08-13 The Brigham And Women's Hospital, Inc. Inhibitors of the BMP signaling pathway
US8338170B2 (en) 2008-04-21 2012-12-25 Viacyte, Inc. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
DK2727998T3 (en) 2008-04-21 2019-08-26 Viacyte Inc Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells
US8728812B2 (en) 2008-04-22 2014-05-20 President And Fellows Of Harvard College Compositions and methods for promoting the generation of PDX1+ pancreatic cells
US8623648B2 (en) 2008-04-24 2014-01-07 Janssen Biotech, Inc. Treatment of pluripotent cells
US20090298178A1 (en) 2008-06-03 2009-12-03 D Amour Kevin Allen Growth factors for production of definitive endoderm
KR20180018839A (en) 2008-06-30 2018-02-21 얀센 바이오테크 인코포레이티드 Differentiation of pluripotent stem cells
US9683215B2 (en) * 2008-08-22 2017-06-20 President And Fellows Of Harvard College Methods of reprogramming cells
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
CN102272291B (en) 2008-10-31 2018-01-16 詹森生物科技公司 Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
CA2742267C (en) * 2008-10-31 2019-06-04 Centocor Ortho Biotech Inc. Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
US8008075B2 (en) 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
PL2356227T3 (en) 2008-11-14 2018-07-31 Viacyte, Inc. CAPSULATION OF Pancreas CELLS ORIGINATING FROM HUMAN PLURIPOTENTIAL STEM CELLS
PL2366022T3 (en) 2008-11-20 2016-11-30 Methods and compositions for cell attachment and cultivation on planar substrates
GB201111244D0 (en) * 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
WO2010091241A2 (en) 2009-02-06 2010-08-12 President And Fellows Of Harvard College Compositions and methods for promoting the generation of definitive endoderm
CN102695511A (en) 2009-04-17 2012-09-26 舒玛健康系统有限责任公司 Use of transforming growth factor-Beta receptor inhibitors to suppress ocular scarring
ES2849181T3 (en) * 2009-04-22 2021-08-16 Viacyte Inc Cell compositions derived from dedifferentiated reprogrammed cells
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
CN102741396B (en) 2009-04-27 2017-10-20 威盛细胞有限公司 Small molecules and methods for supporting growth of pluripotent cells
US9328331B2 (en) * 2009-05-21 2016-05-03 Joslin Diabetes Center, Inc. Compositions and methods for promoting beta cell maturity
RU2540016C2 (en) 2009-07-20 2015-01-27 Янссен Байотек, Инк. Differentiating human embryonic stem cells
MX340952B (en) * 2009-07-20 2016-07-29 Janssen Biotech Inc Differentiation of human embryonic stem cells.
AU2010319921A1 (en) * 2009-10-29 2012-05-17 Janssen Biotech Inc. Pluripotent stem cells
KR101867369B1 (en) 2009-12-23 2018-06-14 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells
CA2785966C (en) * 2009-12-29 2020-10-27 Takeda Pharmaceutical Company Limited Method for manufacturing pancreatic-hormone-producing cells
CA2791476C (en) * 2010-03-01 2020-06-30 Janssen Biotech, Inc. Methods for purifying cells derived from pluripotent stem cells
ES2893699T3 (en) 2010-03-31 2022-02-09 Scripps Research Inst cell reprogramming
US8927274B2 (en) 2010-04-12 2015-01-06 Technion Research & Development Foundation Limited Populations of pancreatic progenitor cells and methods of isolating and using same
JP2013524836A (en) 2010-04-25 2013-06-20 マウント・シナイ・スクール・オブ・メディスン Generation of anterior foregut endoderm from pluripotent cells
AU2011250912A1 (en) * 2010-05-12 2012-11-22 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
AU2011290123B2 (en) * 2010-08-09 2016-11-10 Takeda Pharmaceutical Company Limited Method of producing pancreatic hormone-producing cells
CN103052393B (en) * 2010-08-12 2017-11-14 詹森生物科技公司 Diabetes are treated with pancreatic endocrine progenitor cells
GB201014169D0 (en) 2010-08-25 2010-10-06 Cambridge Entpr Ltd In vitro hepatic differentiation
ES2659393T3 (en) 2010-08-31 2018-03-15 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
KR101836855B1 (en) 2010-08-31 2018-04-19 얀센 바이오테크 인코포레이티드 Differentiation of pluripotent stem cells
RU2620938C2 (en) 2010-08-31 2017-05-30 Янссен Байотек, Инк. Differentiation of human embryonic stem cells
WO2012044486A1 (en) 2010-09-28 2012-04-05 Baylor Research Institute Induction of pancreatic stem cells by transient overexpression of reprogramming factors and pdxi selection
EP2508607A1 (en) 2011-04-07 2012-10-10 Helmholtz-Zentrum für Infektionsforschung GmbH Medicament for liver regeneration and for treatment of liver failure
US20120270890A1 (en) 2011-04-22 2012-10-25 Cheng-Ho Chung Methods of Pancreatic Beta Cell Regeneration
WO2013000084A1 (en) 2011-06-27 2013-01-03 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9199949B2 (en) 2011-06-27 2015-12-01 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
JP6124347B2 (en) 2011-08-02 2017-05-10 石川　哲也 Induction method and production method of hepatic progenitor cells with TGF-β signaling inhibitor and / or Y-27632, and production method of hepatocytes from the hepatic progenitor cells
US20140243374A1 (en) 2011-10-04 2014-08-28 The Brigham And Women's Hospital, Inc. Novel Sulfonamides
EP2768948B1 (en) * 2011-10-18 2017-06-07 Univercell Biosolutions Production of a human beta cell line from an early post natal pancreas
EP2776018B1 (en) 2011-11-13 2021-08-25 Cognitive Research Enterprises, Inc. Pkc activators and combinations thereof
SG11201403473QA (en) * 2011-12-22 2014-10-30 Janssen Biotech Inc Differentiation of human embryonic stem cells into single hormonal insulin positive cells
AR090970A1 (en) 2012-05-07 2014-12-17 Janssen Biotech Inc DIFFERENTIATION OF EMBRYOUS HUMAN MOTHER CELLS IN PANCREATIC ENDODERM
EP2847199B1 (en) 2012-05-08 2017-10-25 Merck Sharp & Dohme Corp. Permeable glycosidase inhibitors and uses thereof
WO2013166654A1 (en) 2012-05-08 2013-11-14 Merck Sharp & Dohme Corp. Permeable glycosidase inhibitors and uses thereof
US10066210B2 (en) 2012-06-08 2018-09-04 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells
SG11201408150UA (en) 2012-06-14 2015-01-29 Janssen Biotech Inc Treatment of pluripotent cells
WO2014033322A1 (en) 2012-09-03 2014-03-06 Novo Nordisk A/S Generation of pancreatic endoderm from pluripotent stem cells using small molecules
RU2018116647A (en) 2012-12-31 2018-10-24 Янссен Байотек, Инк. CULTIVATION OF HUMAN EMBRYONAL STEM CELLS IN THE AIR-LIQUID INTERACTION PURPOSE FOR THEIR DIFFERENTIATION IN PANCREATIC ENDOCRINE CELLS
KR101942769B1 (en) * 2012-12-31 2019-01-28 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
CA2896750A1 (en) 2012-12-31 2014-07-03 Janssen Biotech, Inc. Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
US11920160B2 (en) 2013-02-22 2024-03-05 Cedars-Sinai Medical Center Pancreatic insulin-producing beta-cell lines derived from human pluripotent stem cells
US20140287944A1 (en) 2013-02-26 2014-09-25 President And Fellows Of Harvard College Markers for functionally mature beta-cells and methods of using the same
DK2970205T3 (en) 2013-03-14 2019-07-29 Tolero Pharmaceuticals Inc JAK2 and ALK2 inhibitors and methods for their use
US8859286B2 (en) 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
US20140329704A1 (en) 2013-03-28 2014-11-06 President And Fellows Of Harvard College Markers for mature beta-cells and methods of using the same
CN120796168A (en) 2013-06-11 2025-10-17 哈佛学院校长同事会 SC-beta cells, compositions and methods for producing the same
DK3039122T3 (en) 2013-08-30 2019-09-30 Novo Nordisk As GENERATION OF ENDOCRINE PROGENITOR CELLS FROM HUMAN PLURIPOTENT STEM CELLS USING SMALL MOLECULES
CN117821369A (en) * 2014-05-16 2024-04-05 詹森生物科技公司 Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
CN106661548B (en) 2014-05-28 2020-12-11 儿童医院医疗中心 Methods and systems for converting precursor cells to gastric tissue via directed differentiation
EP3178924B1 (en) 2014-08-04 2019-12-25 Takeda Pharmaceutical Company Limited Method for proliferation of pancreatic progenitor cells
WO2016100909A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF
US20160177268A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Methods for generating augmented stem cell-derived beta cells and uses thereof
WO2016100930A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Methods for generating stem cell-derived b cells and methods of use thereof
US20160175363A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Methods for generating stem cell-derived beta cells and uses thereof
US10443042B2 (en) 2014-12-18 2019-10-15 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof
US9974784B2 (en) 2015-01-21 2018-05-22 The Texas A&M University System Inhibitors of activin-like receptor kinases
WO2017144695A1 (en) 2016-02-24 2017-08-31 Novo Nordisk A/S Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors

Also Published As

Publication number Publication date
GB2557508B (en) 2018-11-07
US20190017031A1 (en) 2019-01-17
EP3008168B1 (en) 2020-02-19
KR102232650B1 (en) 2021-03-29
JP2020108394A (en) 2020-07-16
JP2024054254A (en) 2024-04-16
US20190040362A1 (en) 2019-02-07
CN112226402A (en) 2021-01-15
AU2020289721A1 (en) 2021-01-21
BR112015030946A8 (en) 2020-01-28
GB201521857D0 (en) 2016-01-27
SG11201510176VA (en) 2016-03-30
CA2915088A1 (en) 2015-01-08
RU2019108582A (en) 2019-07-05
JP7766641B2 (en) 2025-11-10
PH12015502767A1 (en) 2016-03-21
US20240124847A1 (en) 2024-04-18
KR20220106230A (en) 2022-07-28
CN106414718A (en) 2017-02-15
US11104883B2 (en) 2021-08-31
KR102423106B1 (en) 2022-07-21
CN110551678B (en) 2024-02-20
KR20160034892A (en) 2016-03-30
CA2915091A1 (en) 2014-12-18
DE202014011287U1 (en) 2019-02-06
KR102580225B1 (en) 2023-09-20
US20150218522A1 (en) 2015-08-06
US20250019661A1 (en) 2025-01-16
GB201622354D0 (en) 2017-02-15
JP6677634B2 (en) 2020-04-08
GB2557508A (en) 2018-06-20
JP2016531087A (en) 2016-10-06
KR20220025151A (en) 2022-03-03
EP3008168A4 (en) 2017-05-31
KR20210034688A (en) 2021-03-30
JP7354026B2 (en) 2023-10-02
WO2014201167A4 (en) 2015-01-29
US20240101963A1 (en) 2024-03-28
EP4461806A3 (en) 2025-02-12
US20220396775A1 (en) 2022-12-15
SG11201510177WA (en) 2016-01-28
JP2023093654A (en) 2023-07-04
AU2020203127C1 (en) 2023-12-21
KR102640729B1 (en) 2024-02-27
RU2016100219A (en) 2017-07-17
AU2023229504A1 (en) 2023-09-28
US20200347358A1 (en) 2020-11-05
KR102361924B1 (en) 2022-02-14
KR20220051442A (en) 2022-04-26
KR20200143750A (en) 2020-12-24
US20150240212A1 (en) 2015-08-27
JP2025063288A (en) 2025-04-15
MX2015017103A (en) 2016-11-07
RU2019108582A3 (en) 2021-08-04
GB2531952C (en) 2019-10-09
WO2014201167A1 (en) 2014-12-18
GB2549822A (en) 2017-11-01
HK1257187B (en) 2020-06-12
JP6893527B2 (en) 2021-06-23
US20230076529A1 (en) 2023-03-09
US20220162562A1 (en) 2022-05-26
JP2021121223A (en) 2021-08-26
US11162078B2 (en) 2021-11-02
DK3008168T3 (en) 2020-05-04
AU2020289721B2 (en) 2023-09-14
US11827905B2 (en) 2023-11-28
GB201803318D0 (en) 2018-04-18
AU2014284677A1 (en) 2016-02-25
KR102205234B1 (en) 2021-01-20
AU2020203127A1 (en) 2020-06-04
GB2531952A (en) 2016-05-04
US12049646B2 (en) 2024-07-30
KR20160099079A (en) 2016-08-19
DE112014002780T5 (en) 2016-06-23
CN105579577A (en) 2016-05-11
AU2014278178B2 (en) 2021-01-21
EP3008170A1 (en) 2016-04-20
GB2557508A9 (en) 2018-09-05
US11078463B2 (en) 2021-08-03
KR20210156337A (en) 2021-12-24
BR112015030972A8 (en) 2020-01-28
WO2015002724A4 (en) 2015-03-26
KR102631225B1 (en) 2024-01-31
RU2016100433A (en) 2017-07-17
RU2692595C2 (en) 2019-06-25
AU2014284677B2 (en) 2020-03-12
US20250043247A1 (en) 2025-02-06
US20190169575A1 (en) 2019-06-06
KR20240014630A (en) 2024-02-01
US10655106B2 (en) 2020-05-19
BR112015030972A2 (en) 2017-07-25
EP3008170A4 (en) 2016-11-09
DE112014002780B4 (en) 2025-05-22
AU2020203127B2 (en) 2023-06-22
KR20230135180A (en) 2023-09-22
MX2019003616A (en) 2019-08-01
WO2015002724A3 (en) 2015-02-26
EP4461806A2 (en) 2024-11-13
KR20230054767A (en) 2023-04-25
EP3008168A2 (en) 2016-04-20
KR102523912B1 (en) 2023-04-21
WO2015002724A2 (en) 2015-01-08
JP2016532436A (en) 2016-10-20
US10030229B2 (en) 2018-07-24
EP3569694A1 (en) 2019-11-20
US20170029778A1 (en) 2017-02-02
JP2019141072A (en) 2019-08-29
US20200385681A1 (en) 2020-12-10
AU2023237028A1 (en) 2023-10-12
KR102201638B1 (en) 2021-01-13
CN120796168A (en) 2025-10-17
RU2016100219A3 (en) 2018-03-30
KR102390167B1 (en) 2022-04-25
US12054745B2 (en) 2024-08-06
BR112015030946A2 (en) 2017-07-25
GB2549822B (en) 2018-05-02
AU2014278178A1 (en) 2016-01-28
US20210079355A1 (en) 2021-03-18
KR102773841B1 (en) 2025-02-27
JP6514689B2 (en) 2019-05-15
CN110551678A (en) 2019-12-10
KR20210008926A (en) 2021-01-25
KR102341674B1 (en) 2021-12-22
GB2531952B (en) 2017-02-08

Similar Documents

Publication Publication Date Title
IL273205A (en) Compositions and methods
GB201622354D0 (en) SC-� Cells and Compositions and methods for generating the same
IL267283A (en) Methods and compositions for generating epicardium cells
GB2533892B (en) Compositions and methods
SMT201900635T1 (en) Compositions and methods for activating
EP2951283A4 (en) Compositions and methods
GB201308072D0 (en) Compositions and methods
IL265876A (en) Compositions comprising 15-ohepa and methods of using the same
SG11201509136YA (en) Cenicriviroc compositions and methods of making and using the same
EP2943591A4 (en) Methods and compositions for single cell expression profiling
GB201305813D0 (en) Compositions and methods
GB201322456D0 (en) Radiotracer compositions and methods
SG11201707615YA (en) Methods and compositions for producing hepatocyte-like cells
EP2964610A4 (en) Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
SG11201604904XA (en) Detergent and rinse-aid compositions and methods
GB201312803D0 (en) Cell component
SG2013029871A (en) Power generating windbags and waterbags
GB201322617D0 (en) Methods and compositions
GB201312393D0 (en) Compositions and Methods
GB201300628D0 (en) Compositions comprising 15-OHEPA and methods of using the same
AU2013902874A0 (en) Compositions and methods